Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer

被引：0
|
作者：
Edwin E Reyes
David J VanderWeele
Masis Isikbay
Ryan Duggan
Alexa Campanile
Walter M Stadler
Donald J Vander Griend
Russell Z Szmulewitz
机构：
[1] University of Chicago,Department of Surgery
[2] University of Chicago,Committee on Immunology
[3] University of Chicago,Department of Medicine
[4] University of Chicago,Flow Cytometry Facility
来源：
Journal of Translational Medicine | / 12卷
关键词：
Prostate neoplasms; Androgen receptor; Circulating tumor cells; Castration-resistant prostate cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Analysis of androgen receptor dynamics through immunofluorescent staining of circulating tumor cells in castration-resistant prostate cancer
    Barnett, Ethan
    Gupta, Santosh
    Erazo, Tatiana
    Carbone, Ernest Lam Emily
    Zanone, Michelle
    Nystrom, Lucy
    Gajar, Ria N.
    Wenstrup, Rick
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Dynamic variations in gene expressions of circulating tumor cells in metastatic castration-resistant prostate cancer patients in response to androgen receptor signaling inhibitors.
    Jan, Yu Jen
    You, Sungyong
    Yoon, Junhee
    Chen, Jie-Fu
    Yao, Nu
    Cheng, Shirley
    Freeman, Michael
    Tseng, Hsian-Rong
    Posadas, Edwin M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel
    de Kruijff, Ingeborg E.
    Sieuwerts, Anieta M.
    Onstenk, Wendy
    Kraan, Jaco
    Smid, Marcel
    Van, Mai N.
    van der Vlugt-Daane, Michelle
    Oomen-de Hoop, Esther
    Mathijssen, Ron H. J.
    Lolkema, Martijn P.
    de Wit, Ronald
    Hamberg, Paul
    Meulenbeld, Hielke J.
    Beeker, Aart
    Creemers, Geert-Jan
    Martens, John W. M.
    Sleijfer, Stefan
    CANCERS, 2019, 11 (08)
  • [24] The use of circulating tumor cells in guiding treatment decisions for patients with metastatic castration-resistant prostate cancer
    Onstenk, Wendy
    de Kiaver, Willemijn
    de Wit, Ronald
    Lolkema, Martijn
    Foekens, John
    Sleijfer, Stefan
    CANCER TREATMENT REVIEWS, 2016, 46 : 42 - 50
  • [25] CD133 expression in circulating tumor cells (CTCs) from metastatic castration-resistant prostate cancer (mCRPC).
    Ana Marcos, Rosa
    Alfonso, Sara
    Lozano, Rebeca
    Matos, Ignacio
    Espinet, Blanca
    Garcia, Rocio
    Maria Hernandez, Jesus
    Gomez-Veiga, Francisco
    Luis Hernandez, Juan
    Cruz, Juan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] Association of Circulating Tumor Cells with Inflammatory and Biomarkers in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer
    Theil, Gerit
    Lindner, Carlotta
    Bialek, Joanna
    Fornara, Paolo
    LIFE-BASEL, 2021, 11 (07):
  • [27] A novel transcript variant of androgen receptor identified in circulating tumor cells from castration-resistant prostate cancer patients as a potentially prognostic biomarker
    Kang, Zhigang
    Shah, Avani
    Yu, Yunkai
    Zhu, Yuelin
    Bhagat, Ali Asgar
    Zhao, Kyra
    Wu, Andrew
    Gao, James
    Madan, Ravi
    Gulley, James
    Dahut, William
    Meltzer, Paul
    Cao, Liang
    CANCER RESEARCH, 2015, 75
  • [28] Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
    de Bono, Johann S.
    Scher, Howard I.
    Montgomery, R. Bruce
    Parker, Christopher
    Miller, M. Craig
    Tissing, Henk
    Doyle, Gerald V.
    Terstappen, Leon W. W. M.
    Pienta, Kenneth J.
    Raghavan, Derek
    CLINICAL CANCER RESEARCH, 2008, 14 (19) : 6302 - 6309
  • [29] Quantitative image analysis of androgen receptor (AR) and tubulin biomarker profiles in circulating tumor cells (CTCs) from metastatic castration resistant prostate cancer (mCRPC) patients
    Worroll, Daniel
    Galletti, Giuseppe
    Nanus, David M.
    Tagawa, Scott T.
    Giannakakou, Paraskevi
    CANCER RESEARCH, 2016, 76
  • [30] Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer
    Maillet, Denis
    Allioli, Nathalie
    Peron, Julien
    Plesa, Adriana
    Decaussin-Petrucci, Myriam
    Tartas, Sophie
    Sajous, Christophe
    Ruffion, Alain
    Crouzet, Sebastien
    Freyer, Gilles
    Vlaeminck-Guillem, Virginie
    CANCERS, 2021, 13 (23)
12345